Show simple item record

dc.contributor.authorLevy, K.D.
dc.contributor.authorBlake, K.
dc.contributor.authorFletcher-Hoppe, C.
dc.date.accessioned2019-03-29T14:47:37Z
dc.date.available2019-03-29T14:47:37Z
dc.date.issued2019
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85049676333&doi=10.1038%2fs41436-018-0080-y&partnerID=40&md5=fa440ba2f0573714ca116b205aef5092
dc.identifier.urihttp://hdl.handle.net/10713/8697
dc.descriptionThe original version of this Article contained an error in the spelling of the author Geoffrey S. Ginsburg, which was incorrectly given as Geoffrey Ginsburg. This has now been corrected in both the PDF and HTML versions of the Article. DOI 10.1038/s41436-018-0280-5
dc.description.abstractPurpose: While there is growing scientific evidence for and significant advances in the use of genomic technologies in medicine, there is a significant lag in the clinical adoption and sustainability of genomic medicine. Here we describe the findings from the National Human Genome Research Institute's (NHGRI) Implementing GeNomics In pracTicE (IGNITE) Network in identifying key constructs, opportunities, and challenges associated with driving sustainability of genomic medicine in clinical practice. Methods: Network members and affiliates were surveyed to identify key drivers associated with implementing and sustaining a genomic medicine program. Tallied results were used to develop and weigh key constructs/drivers required to support sustainability of genomic medicine programs. Results: The top three driver-stakeholder dyads were (1) genomic training for providers, (2) genomic clinical decision support (CDS) tools embedded in the electronic health record (EHR), and (3) third party reimbursement for genomic testing. Conclusion: Priorities may differ depending on healthcare systems when comparing the current state of key drivers versus projected needs for supporting genomic medicine sustainability. Thus we provide gap-filling guidance based on IGNITE members' experiences. Although results are limited to findings from the IGNITE network, their implementation, scientific, and clinical experience may be used as a road map by others considering implementing genomic medicine programs. Copyright 2018, The Author(s).en_US
dc.description.urihttps://dx.doi.org/10.1038/s41436-018-0080-yen_US
dc.description.urihttps://doi.org/10.1038/s41436-018-0280-5
dc.language.isoen_USen_US
dc.publisherNature Publishing Groupen_US
dc.relation.ispartofGenetics in Medicine
dc.subjectgenomic educationen_US
dc.subjectIGNITE Networken_US
dc.subjectsustainabilityen_US
dc.subject.meshGenomicsen_US
dc.subject.meshImplementation Scienceen_US
dc.titleOpportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Networken_US
dc.typeArticleen_US
dc.identifier.doi10.1038/s41436-018-0080-y
dc.identifier.pmid29997387


This item appears in the following Collection(s)

Show simple item record